Global Leader in Gynaecologic Oncology to Keynote ANZGOG Annual Scientific Meeting The Australia New Zealand Gynaecology Oncology Group (ANZGOG) is delighted to welcome Dr. Lisa Bazzett-Matabele, a distinguished gynaecological oncologist and global health advocate, as an international keynote speaker [...]
Be the Voice That Makes a Difference: Survivors Teaching Students Webinar on 27 February The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is calling on people with a lived experience of ovarian and other gynaecological cancers, including those personally [...]
Ovarian cancer is now confirmed as the deadliest women’s cancer, with the latest statistics revealing a five-year survival rate of just 49%. Tragically, two-thirds (67%) of cases are diagnosed at an advanced stage, where survival drops to just 29%1. [...]
The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is pleased to welcome internationally renowned Radiation Oncologist Professor Carien Creutzberg as a keynote speaker at the 2024 ANZGOG Annual Scientific Meeting (ASM), taking place in Canberra from 5-7 March 2025. [...]
The Australia New Zealand Gynaecological Oncology Group (ANZGOG) is thrilled to announce it has been awarded $1.58 million over three years (2024-2027) as part of the Australian Government’s $22.19 million investment in cancer clinical trials through the Support [...]
RAMP 301 (VS-6766-301/GOG-3097/ENGOT-ov81) is a Phase 3, Randomized, Open-Label Study of Combination Therapy with Avutometinib plus Defactinib Versus Investigator’s Choice of Treatment in Patients with Recurrent Low-Grade Serous Ovarian Cancer (LGSOC). We’re excited to announce [...]
Awarded a $2m Medical Research Future Fund government grant for the PARAGON-II study, Principal Investigator Associate Professor Chee Lee speaks about the study aims. The study follows on from PARAGON, an ANZGOG trial that pioneered [...]
ANZGOG attends Asia Pacific Gynecologic Oncology Trials Group (APGOT) meeting in Singapore. APGOT in Singapore ANZGOG leader Prof Michael Friedlander AM and CEO Alison Evans were in Singapore in November, discussing an [...]
New leiomyosarcoma research concept awarded the Rochelle Fisher Grant Rochelle Fisher has raised over $30K for ANZGOG leiomyosarcoma research Congratulations to Dr Genevieve Dall, whose pre-clinical research concept has been awarded the [...]
Principal Investigator Professor Sandi Hayes comments on ECHO, the first ever exercise intervention clinical trial run by ANZGOG. Prof Sandi Hayes, ECHO PI It has been an exciting, productive past 18 months [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2024 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
